These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20890423)

  • 1. Clinicopathological significance of expression of Tspan-1, Jab1 and p27 in human hepatocellular carcinoma.
    Chen L; Yuan D; Wang GL; Wang Y; Wu YY; Zhu J
    J Korean Med Sci; 2010 Oct; 25(10):1438-42. PubMed ID: 20890423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis.
    Wang Y; Yu YN; Song S; Li TJ; Xiang JY; Zhang H; Lu MD; Ji F; Hu LQ
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):969-78. PubMed ID: 24671224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
    Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
    Ahn J; Hong SA; Lee SE; Kim J; Oh YS; Park SJ; Chung YJ
    Endocr J; 2009; 56(5):707-13. PubMed ID: 19461157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma.
    Wang Y; Wang Y; Cheng C; Ji Y; Zhao Y; Zou L; Shen A
    J Cancer Res Clin Oncol; 2009 Jul; 135(7):951-9. PubMed ID: 19139918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27.
    Gao L; Huang S; Ren W; Zhao L; Li J; Zhi K; Zhang Y; Qi H; Huang C
    Med Oncol; 2012 Dec; 29(4):2499-504. PubMed ID: 22311264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of arsenic trioxide on proliferation of human hepatocellular carcinoma cell line SMMC-7721 and the mechanism].
    Cui XP; Wang Y; Lu MD; Li P; Shen AG
    Ai Zheng; 2007 Dec; 26(12):1304-8. PubMed ID: 18076791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma.
    Qin J; Wang Z; Wang Y; Ma L; Ni Q; Ke J
    Hepatogastroenterology; 2010; 57(99-100):547-53. PubMed ID: 20698225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
    Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
    Wang F; Wang Y; Yu X; Yang D; Wang Z; Lu C; Yuan Z; Xiao M; Shen A
    J Clin Gastroenterol; 2009 Jul; 43(6):520-6. PubMed ID: 19349901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
    Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma.
    Pan Y; Zhang Q; Tian L; Wang X; Fan X; Zhang H; Claret FX; Yang H
    Cancer Res; 2012 Apr; 72(7):1890-900. PubMed ID: 22350412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A7, Jab1, and p27
    Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
    J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of Ser10 phosphorylated p27(kip1) and JAB1 protein in human hepatocellular carcinoma].
    Lu MD; Wang Y; Chen L; Qin J; Li P; Cui XP; Shen AG
    Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):840-1. PubMed ID: 18346358
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.
    Kouvaraki MA; Korapati AL; Rassidakis GZ; Tian L; Zhang Q; Chiao P; Ho L; Evans DB; Claret FX
    Cancer Res; 2006 Sep; 66(17):8581-9. PubMed ID: 16951171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.
    Guo H; Jing L; Cheng Y; Atsaves V; Lv Y; Wu T; Su R; Zhang Y; Zhang R; Liu W; Rassidakis GZ; Wei Y; Nan K; Claret FX
    Hepatology; 2016 Mar; 63(3):898-913. PubMed ID: 26606000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of c-jun-activation-domain binding protein (JAB1) in hepatocellular carcinoma].
    Qin J; Wang ZW; Ni QC; Wang Y; Chen L; Lu MD; Shen AG
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2533-6. PubMed ID: 19080643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
    Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W
    Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
    Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.